HIV、乙型肝炎、丙型肝炎与结核共感染的治疗复杂性
本文通过一名有静脉吸毒史的年轻男性病例,描述其同时感染HIV、HBV、HCV并罹患播散性结核的治疗过程。先启动抗结核治疗,2个月后加用对HIV和HBV均有效的抗逆转录病毒药物,抗结核治疗9个月后以12周口服直接抗病毒药物治疗HCV成功。文章讨论了抗结核药、抗逆转录病毒药、抗HBV药及抗HCV直接抗病毒药之间的药物相互作用与治疗方案制定挑战。
要点
- HIV/HBV/HCV与结核共感染时需兼顾疗效、药物相互作用和不良反应制定方案。
- 该病例先抗结核、2个月后加抗逆转录病毒药,9个月抗结核后以12周DAA治愈HCV。
- 抗结核药、抗逆转录病毒药、抗HBV药与HCV DAA间存在多种药物相互作用需关注。
核心结论
- HIV、HBV、HCV与结核共感染的治疗方案制定复杂,需综合管理药物相互作用与不良反应。
研究设计与样本
- 本文为病例报告,对象为一名有静脉吸毒史的年轻男性,诊断为播散性结核并三重感染HBV、HCV和HIV。
主要发现
- 先启动抗结核治疗,2个月后加用对HIV和HBV均有效的抗逆转录病毒药物。
- 抗结核治疗9个月后,以12周口服直接抗病毒药物成功治疗HCV。
- 文章描述了制定治疗方案面临的挑战及抗结核药、抗逆转录病毒药、抗HBV药与HCV DAA之间的多种药物相互作用。
临床怎么用
- 共感染患者应分阶段启动治疗并关注抗结核药、抗逆转录病毒药、抗HBV药与HCV DAA间的相互作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
HIV, hepatitis B virus (HBV), and hepatitis C virus (HCV) are commonly encountered blood-borne infectious microorganisms. Infection with these viruses typically requires long-lasting drug therapy. Coinfections, especially with tuberculosis, pose a challenge to the creation of a regimen with adequate efficacy and minimal drug-drug interactions and adverse effects. We present the case of a young man with a history of intravenous drug misuse who was diagnosed with disseminated tuberculosis and with a triple infection with HBV, HCV, and HIV. The treatment for tuberculosis was initiated first, followed 2 months later by antiretrovirals that were effective against both HIV and HBV. After 9 months of antitubercular therapy, HCV was successfully treated with 12 weeks of oral direct-acting antivirals. We describe the challenges faced in formulating a therapeutic plan for such patients and discuss the various drug interactions that can arise between antitubercular drugs, antiretrovirals, anti-HBV drugs, and direct-acting antivirals against HCV.
引用
- Arora U, Garg P, Agarwal S, et al. Complexities in the treatment of coinfection with HIV, hepatitis B, hepatitis C, and tuberculosis. Lancet Infect Dis. 2021. PMID: 34023004. doi:10.1016/S1473-3099(20)30765-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。